Pfizer Reports Death of Participant in DMD Gene Therapy Trial

Pfizer Reports Death of Participant in DMD Gene Therapy Trial

314885

Pfizer Reports Death of Participant in DMD Gene Therapy Trial

A young man with Duchenne muscular dystrophy (DMD), who was participating in Pfizer’s Phase 1B open-label clinical trial evaluating its gene therapy candidate PF-06939926, has died. The patient has only been identified as a young man who was not able to walk. In a statement, Pfizer expressed its sympathies to the man’s family, friends, and caregivers. The company also indicated that it does not have all the information regarding his case, but that researchers are engaged…

You must be logged in to read/download the full post.